Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-1143-2023

Drug recall · September 13, 2023

Nexlizet recall

Why: Failed dissolution specifications: below specification results at stability 12-month

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion Therapeutics, Inc, Ann Arbor, MI 48108, NDC 72426-818-03

Lots / codes

Lot# 1904872, Exp 1/31/2025; 1950377, Exp 6/30/2025

Quantity
45,240 bottles
Company
Esperion, Ann Arbor, MI
Distribution
Nationwide USA
Initiated
August 16, 2023 · Voluntary: Firm initiated
Classified
September 6, 2023
Reported
September 13, 2023
Ended
August 31, 2026
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Nexlizet

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.